Xenetic Biosciences Total Non Current Liabilities 2011-2026 | XBIO

Annual Total Non Current Liabilities Xenetic Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	27 K	2.92 M	2.92 M	2.92 M	2.94 M	2.96 M	3.14 M	213 K	213 K	213 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.14 M	27 K	1.85 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Celldex Therapeutics CLDX	17.3 M	$ 34.83	2.85 %	$ 2.31 B	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 4.3	8.31 %	$ 10.3 B	Australia
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Akari Therapeutics, Plc AKTX	50 K	$ 5.98	16.72 %	$ 403 B	Britain
Aligos Therapeutics ALGS	15 M	$ 6.69	-12.73 %	$ 66.1 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Alnylam Pharmaceuticals ALNY	604 M	$ 307.49	-3.95 %	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 22.72	4.17 %	$ 1.06 B	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
BioNTech SE BNTX	341 M	$ 103.65	1.5 %	$ 27.2 B	Germany
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.09	0.32 %	$ 5.09 M	Israel
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
BioXcel Therapeutics BTAI	1.4 M	$ 1.17	9.67 %	$ 14.3 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	168 M	$ 1.41	5.19 %	$ 363 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	90.3 M	$ 4.33	1.69 %	$ 463 M	USA
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
Arcutis Biotherapeutics ARQT	167 M	$ 24.54	1.43 %	$ 3.12 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Cabaletta Bio CABA	43.9 M	$ 3.33	-5.4 %	$ 335 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.67	3.5 %	$ 444 M	Britain
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Cidara Therapeutics CDTX	942 K	-	-	$ 1.41 B	USA
Citius Pharmaceuticals CTXR	6.01 M	$ 0.87	1.44 %	$ 5.85 M	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA